U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07055984) titled 'Predicting Outcomes in Posttransplant Diabetes Mellitus Via microRNA' on June 09.
Brief Summary: The study aims to improve the prediction and early detection of post-transplant diabetes mellitus (PTDM) in kidney transplant recipients. The investigators are investigating whether specific microRNA profiles measured 3 months after transplantation can reliably predict the development of PTDM within the following one to two years.
Additionally, the investigators are evaluating how traditional risk factors-such as age, immunosuppressive therapy, obesity, and infections like CMV-interact with these microRNA markers.
The ultimate goal of ...